deltatrials

Neuroblastoma Trials in Chicago, United States

Conditions / Neuroblastoma / Chicago, United States

Research into Neuroblastoma spans multiple therapeutic approaches and trial phases.

61 total trials for this combination

Showing top 10 of 61 trials

Trials

NCT ID Title Status Phase
NCT02176967 Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma ACTIVE_NOT_RECRUITING PHASE3
NCT00898755 Collecting and Storing Tissue From Young Patients With Cancer COMPLETED
NCT06172296 Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma RECRUITING
NCT00003093 Combination Chemotherapy in Treating Children With Neuroblastoma COMPLETED PHASE3
NCT06172296 Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma RECRUITING
NCT00003119 Surgery in Treating Children With Neuroblastoma COMPLETED PHASE3
NCT00716976 Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy COMPLETED PHASE3
NCT00006102 Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma COMPLETED PHASE2
NCT00003234 Vinorelbine in Treating Children With Recurrent or Refractory Cancers COMPLETED PHASE2
NCT06172296 Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma RECRUITING

Related Pages